Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This study evaluates the diagnostic performance of 18F-2-fluoro-2-deoxy-D-glucose fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) with rest perfusion imaging for the diagnosis of myocarditis. Patients with clinical suspicion of myocarditis will be recruited and undergo a rest myocardial perfusion scan and a FDG PET/CT scan following a myocardial suppression protocol.
Myocarditis is characterized by myocardial inflammation, which can lead to fibrosis and heart failure.
FDG PET/CT, with appropriate suppression protocol including high-fat-low-carbohydrate diet, fasting, and IV heparin, can be use to detect myocardial inflammation. It is frequently used for the diagnosis of inflammation in cardiac sarcoidosis. After the initial inflammatory phase, inflammation resolves and fibrosis can seen. Resting perfusion imaging will allow identification of fibrosis. The combination of FDG PET/CT and rest perfusion imaging could allow detection of the various phases of myocarditis; inflammation and fibrosis.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| FDG PET/CT | Diagnostic Test | FDG PET CT imaging with rest perfusion imaging |
| Measure | Description | Time Frame |
|---|---|---|
| Sensitivity of FDG PET/CT imaging with rest perfusion imaging to detect myocarditis | Sensitivity of FDG-PET/CT with rest perfusion imaging | 1 year |
| Measure | Description | Time Frame |
|---|---|---|
| Specificity and accuracy of FDG-PET/CT with rest perfusion imaging to detect myocarditis | Specificity and accuracy of FDG-PET/CT with rest perfusion imaging | 1 year |
| Left ventricular ejection fraction |
Not provided
Inclusion Criteria:
18 years of age or older
Clinical suspicion of myocarditis due to findings such as:
Women of childbearing potential must have a negative urine or blood pregnancy test
Capable of giving informed consent and the consent must be obtained prior to any study related procedures
Subject's with body mass index inferior or equal to 45 kg/m2
Exclusion Criteria:
Not provided
Not provided
Not provided
A total of 50 subjects with high clinical suspicion of myocarditis will be enrolled.
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Matthieu Pelletier-Galarneau | Montreal | Quebec | H3L3C1 | Canada |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D009205 | Myocarditis |
| ID | Term |
|---|---|
| D009202 | Cardiomyopathies |
| D006331 | Heart Diseases |
| D002318 | Cardiovascular Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
The association between subjects' outcome and quantitative assessment of left ventricular inflammation and scar will be evaluated
| 1 year |